Alnylam Pharmaceuticals
ALNY
#510
Rank
C$65.71 B
Marketcap
C$497.39
Share price
-0.17%
Change (1 day)
29.68%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company